Cargando…

Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis

BACKGROUND: Postmenopausal osteoporosis (PMOP) has a supernal morbidity rate in elderly females. OBJECTIVE: To appraise the effects of oleuropein on bone densitometry, bone metabolic index, oxidative stress, and inflammatory index in PMOP. In addition, the mechanism of olive bittersweet preventing b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huilan, Zhao, Aiguo, Huang, Yulu, Hou, Anli, Miao, Wenbin, Hong, Lu, Deng, Nina, Fan, Yujuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436544/ https://www.ncbi.nlm.nih.gov/pubmed/36060661 http://dx.doi.org/10.1155/2022/9767113

Ejemplares similares

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Oleuropein-Laded Ufasomes Improve the Nutraceutical Efficacy
por: Cristiano, Maria Chiara, et al.
Publicado: (2021)

Structure Properties, Acquisition Protocols, and Biological Activities of Oleuropein Aglycone
por: Xu, Fangxue, et al.
Publicado: (2018)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis
por: Hou, Anli, et al.
Publicado: (2020)

Oleuropein, unexpected benefits!
por: Sun, Wenyan, et al.
Publicado: (2017)

Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-Analysis
por: Gu, Hai-Feng, et al.
Publicado: (2015)

In silico analysis of the molecular mechanism of postmenopausal osteoporosis
por: LIU, YANQING, et al.
Publicado: (2015)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao, Yuzhang, et al.
Publicado: (2021)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Novel Scaffolds Fabricated Using Oleuropein for Bone Tissue Engineering
por: Fan, Hui, et al.
Publicado: (2014)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
por: Zhu, Yilin, et al.
Publicado: (2019)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Oleuropein in Olive and its Pharmacological Effects
por: Omar, Syed Haris
Publicado: (2010)

Oleuropein and Cancer Chemoprevention: The Link is Hot
por: Ahmad Farooqi, Ammad, et al.
Publicado: (2017)

Soft-MS and Computational Mapping of Oleuropein
por: Gentile, Luigi, et al.
Publicado: (2017)

Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints
por: Chen, Guizhen, et al.
Publicado: (2020)

Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis
por: Peng, Lihua, et al.
Publicado: (2017)

SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
por: Sun, Xiaolei, et al.
Publicado: (2023)

Gastrointestinal disease is an important influencing factor of osteoporosis fracture:a retrospective study in chinese postmenopausal women
por: Xu, PengChao, et al.
Publicado: (2023)

Investigation of candidate genes and mechanisms underlying postmenopausal osteoporosis using bioinformatics analysis
por: Zhu, Xiaozhong, et al.
Publicado: (2018)

Cytokine-scavenging nanodecoys reconstruct osteoclast/osteoblast balance toward the treatment of postmenopausal osteoporosis
por: Zhou, Yang, et al.
Publicado: (2021)

Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
por: Deng, Jing, et al.
Publicado: (2018)

Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding
por: Zhao, Shuya, et al.
Publicado: (2023)

Association between Postmenopausal Osteoporosis and Experimental Periodontitis
por: Luo, Kai, et al.
Publicado: (2014)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Introduction to the Guidelines on Menopause and Postmenopausal Osteoporosis
por: Meeta, Meeta
Publicado: (2020)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s49pbva3bcsvaaclo11bqm8sff